Tanabe Pharma Accelerates Transformation with Veeva's Next-Generation CRM Solution

Tanabe Pharmaceutical Company has made a strategic move by implementing Veeva's next-generation CRM platform, Veeva Vault CRM, marking a significant step towards becoming a data-driven organization. This system aims to unify the various divisions of sales, marketing, and medical departments on a single platform, utilizing a common customer database and artificial intelligence (AI) agents to enhance productivity and deliver a higher quality customer experience.

The Chief Information Officer and Head of Digital IT at Tanabe Pharma, Keitaro Shigemasa, expressed the company’s vision of providing hope and choices for everyone in the face of illness. He stated, "Our mission is to pursue the creation of groundbreaking pharmaceuticals while enhancing corporate value. Our vision, ‘All are Innovative,’ reflects our commitment to making each individual the starting point of innovation, developing life-changing medicines. To realize this vision, we adopted Veeva Vault CRM due to its established track record in the industry and its continuous functional innovations, which will enable us to deliver advanced medical information quickly through digital technologies."

Marketing Executive Officer of Tanabe Pharma, Kiyoshi Kawano, highlighted the advantages of Veeva Vault CRM in a collaborative environment. He stated, “The unique aspect of Veeva Vault CRM is that it creates a physical collaborative environment where sales, marketing, and medical departments can work together on a single platform and utilize one shared database. Furthermore, its seamless integration with Veeva PromoMats and the use of Veeva AI agents will allow each department to streamline their operations and focus more effectively on providing medical information.”

Veeva Japan’s General Manager, Hirotaka Chiba, conveyed his pride in supporting Tanabe Pharma’s innovations in the commercial sector through Vault CRM and Veeva AI. He believes that the new commercial strategy will contribute significantly to the growth of Japan's pharmaceutical industry as a whole. "We are honored to be part of this initiative, and we are confident that it will foster other developments in the industry," he remarked.

About Veeva Systems

Veeva is a company that specializes in providing cloud services for the life sciences sector through software, AI, data, and consulting. With a commitment to innovation, exceptional products, and customer success, Veeva serves over 1,500 customers, ranging from the largest biopharmaceutical companies to emerging biotechnology firms. As a Public Benefit Corporation, Veeva is dedicated to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries they serve. For more information, please visit www.veeva.com/jp/.

Forward-Looking Statements

This release includes forward-looking statements relating to Veeva's products and services and the anticipated outcomes or benefits from their use. These statements are based on current expectations, and actual results may significantly differ owing to various risks and uncertainties. The detailed risks impacting our results are disclosed in our filings on Form 10-K for the fiscal year ending January 31, 2026, available at sec.gov.

For additional updates from Veeva, follow us on LinkedIn: jp.linkedin.com/company/veeva-japan.